Sierra Nevada (southern Iberian Peninsula) harbours a great biodiversity and the studies on some aquatic insect groups have been and continue to be numerous there. This database brings together information on Plecoptera, Trichoptera and Coleoptera inhabiting running waters of this mountain system above 800 m of altitude. It includes data on the number, life stage and sex of individuals as well as the available information on abiotic characteristics of their habitats. The dataset is composed of 1,718 sampling events carried out between 1901 and 2022 in approximately 60 different water bodies, 15,347 occurrences pertaining to more than 203,000 individuals, and 10,173 records of associated measurements (23 physico-chemical parameters). The dataset is the result of a comprehensive review of scientific literature and of integrating data from recent research projects and the Sierra Nevada Global-Change Observatory's long-term monitoring data. This information is valuable for those studying past distributions and abundances of the species in the dataset, for building predictive models or just studying temporal trends in the current context of climate change.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11269697PMC
http://dx.doi.org/10.1038/s41597-024-03652-yDOI Listing

Publication Analysis

Top Keywords

sierra nevada
12
plecoptera trichoptera
8
trichoptera coleoptera
8
distribution habitat
4
habitat database
4
database fluvial
4
fluvial plecoptera
4
coleoptera sierra
4
nevada spain
4
spain sierra
4

Similar Publications

Recent developments in treatments for both forms of advanced age-related macular degeneration (AMD) have led to the approval of multiple agents and modalities within the last few years. Five new medications for both neovascular AMD (nAMD) and geographic atrophy (GA) secondary to nonexudative AMD (neAMD) have been FDA-approved within the last 5 years, along with a new device designed for sustained drug delivery for nAMD. In nAMD, the newest agents approved by the FDA are brolucizumab (Novartis Pharmaceuticals, Basel, Switzerland), faricimab (F.

View Article and Find Full Text PDF

Background: Understanding the impacts of climate change on forest aboveground biomass is a high priority for land managers. High elevation subalpine forests provide many important ecosystem services, including carbon sequestration, and are vulnerable to climate change, which has altered forest structure and disturbance regimes. Although large, regional studies have advanced aboveground biomass mapping with satellite data, typically using a general approach broadly calibrated or trained with available field data, it is unclear how well these models work in less prevalent and highly heterogeneous forest types such as the subalpine.

View Article and Find Full Text PDF

Pacific Coast tick fever is a recently described zoonotic disease in California caused by a spotted fever group rickettsia, Rickettsia rickettsii subsp. californica (formerly Rickettsia 364D) and transmitted by the Pacific Coast tick, Dermacentor occidentalis. Like many emerging vector-borne diseases, knowledge regarding the transmission cycle, contribution from potential amplifying hosts, and geographic distribution of R.

View Article and Find Full Text PDF

Background Incidental findings of coronary artery calcifications (CACs) are not consistently reported, and the clinical significance relating to cardiovascular outcomes remains to be established. In this single-center cross-sectional study, we assessed the association between incidental coronary artery calcification documented on formal chest CT reports and the incidence of major adverse cardiovascular events (MACE). Methods A MACE was defined as the occurrence of stroke or transient ischemic attack or ST-segment elevation myocardial infarction, non-ST-elevation myocardial infarction, or undergoing coronary artery bypass grafting.

View Article and Find Full Text PDF

Background: Investigate retinal fluid changes via a novel deep-learning algorithm in real-world patients receiving faricimab for the treatment of neovascular age-related macular degeneration (nAMD).

Methods: Multicenter, retrospective chart review and optical coherence tomography (OCT) image upload from participating sites was conducted on patients treated with faricimab for nAMD from February 2022 to January 2024. The Notal OCT Analyzer (NOA) algorithm provided intraretinal, subretinal and total retinal fluid for each scan.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!